Biopharmaceutical company Sarepta Therapeutics, which specializes in developing therapies for rare and infectious diseases, has been waiting for approval from…
Articles by Margarida Azevedo, MSc
A group of investigators from the Massachusetts Institute of Technology (MIT) recently joined forces with the Myotonic Dystrophy Foundation (MDF)…
Investigators from the Helmholtz Zentrum München and Ludwig-Maximilians-Universität München in Germany are organizing a crowd sourcing exercise as a way of determining new algorithms…
A group of researchers from Richland, Washington-based Pacific Northwest National Laboratory recently conducted a study that made use of an…
The Italian Government recently approved the protein restoration therapy Translarna (ataluren) for the treatment of Duchenne muscular dystrophy (DMD), and included…
A novel RNA-based drug from specialized biotech company, Sarepta Therapeutics, Inc., is experiencing a delay in its New Drug Application…
The American Academy of Neurology (AAN) and the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) recently released new…
New discoveries in the laboratory are leading to exciting, new possibilities for developing the next generation of Muscular dystrophy…
Clinical stage biopharmaceutical company Akashi Therapeutics recently acquired the rights for a peptide therapy to regulate the calcium levels in the muscles,…
Beverly Hills, California-based Capricor Therapeutics, Inc. has just announced plans to explore the potential of using one of their leading pipeline…